-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vor Biopharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Vor Biopharma Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$28.5M, a 19.3% increase year-over-year.
- Vor Biopharma Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$118M, a 3.78% increase year-over-year.
- Vor Biopharma Inc. annual Operating Income (Loss) for 2023 was -$126M, a 34.9% decline from 2022.
- Vor Biopharma Inc. annual Operating Income (Loss) for 2022 was -$93.4M, a 35.4% decline from 2021.
- Vor Biopharma Inc. annual Operating Income (Loss) for 2021 was -$69M, a 59.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)